Cardiac lipid droplets differ under pathological and physiological conditions.

Area of Science:

• Cardiovascular Biology
• Cellular Metabolism
• Lipid Biology

Background:

• Excessive lipid accumulation in cardiomyocytes can lead to cardiomyopathy.
• Understanding the mechanisms differentiating harmful versus non-harmful lipid accumulation is crucial.

Purpose of the Study:

• To investigate the differences in lipid droplet (LD) size, composition, and metabolism between pathologic and non-pathologic states in cardiomyocytes.
• To elucidate the role of lipolysis and lipophagy in cardiomyocyte lipid handling and cardiotoxicity.

Main Methods:

• Isolation and proteomic analysis of LD-associated membrane proteins (LDAMPs) from genetically altered and wild-type mouse lines.
• Transmission electron microscopy (TEM) and cardiac immunofluorescence staining of cardiomyocytes.
• Analysis of lipid content, including diacylglycerols and ceramides.

Main Results:

• MHC-Pparg1 transgenic mice exhibited larger LDs with reduced perilipin (PLIN) and increased lipolytic proteins, indicating active lipolysis.
• MHC-Dgat1 transgenic mice showed increased lipophagy and mitochondrial proteins, with reduced lipolytic enzymes.
• Potentially toxic lipids (diacylglycerols, ceramides) increased in MHC-Pparg1 hearts, correlating with cardiotoxicity.

Conclusions:

• Cardiomyocyte LDs exhibit significant variation in size, composition, and metabolic activity.
• Cardiotoxicity is associated with enhanced LD lipolysis, leading to the intracellular release of toxic lipids, rather than simple lipid accumulation.